000172744 000__ 01318fam\a2200301\a\4500
000172744 001__ 172744
000172744 005__ 20220217103503.0
000172744 008__ 881123s1988\\\\dcuak\\\\b\\\f00000\eng\d
000172744 035__ $$9(IS)TVJ0505
000172744 035__ $$9AAU0602SI
000172744 035__ $$a172744
000172744 040__ $$aGPO$$cGPO
000172744 043__ $$an-us---
000172744 074__ $$a1016-A, 1016-B (microfiche)
000172744 0860_ $$aY 4.G 74/7:F 73/13
000172744 099__ $$aY 4.G 74/7:F 73/13
000172744 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Government Operations.$$bHuman Resources and Intergovernmental Relations Subcommittee.
000172744 24510 $$aFDA's regulation of the new drug Versed :$$bhearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
000172744 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,$$c1988.
000172744 300__ $$aiii, 599 p. :$$bill., forms ;$$c24 cm.
000172744 500__ $$aDistributed to some depository libraries in microfiche.
000172744 500__ $$aShipping list no.: 88-680-P.
000172744 504__ $$aIncludes bibliographies.
000172744 61010 $$aUnited States.$$bFood and Drug Administration.
000172744 650_0 $$aDrugs$$xToxicology$$zUnited States.
000172744 650_0 $$aAnesthetics$$zUnited States$$xPhysiological effect.
000172744 650_0 $$aDrugs$$zUnited States$$xTesting.
000172744 85230 $$bdfich$$hY 4.G 74/7:$$iF 73/13
000172744 909CO $$ooai:library.usi.edu:172744$$pGLOBAL_SET
000172744 948__ $$ac:jk
000172744 980__ $$aBIB
000172744 980__ $$aGOV RESOURCE